Clinical Trials Directory

Trials / Terminated

TerminatedNCT01388686

Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg

Retrospective Analysis of Proven Bacteremia, CVC-associated Infections and Sepsis

Status
Terminated
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Structured web-based survey in selected hospitals with intensive care units in Berlin- Brandenburg to collect data on the overall number of blood cultures (used) and the prevalence of (positive blood cultures in patients with) CVC - associated sepsis.

Detailed description

The use of CVC represents one of the major risk factors for sepsis, a highly prevalent disease in ICUs. Blood cultures obtained prior to antibiotic administration are part of the SSC Resuscitation Bundle and essential for the outcome of the patient. The CDC criteria to diagnose sepsis do not take into account the overall number of blood cultures obtained and thus, lead to an underestimation of the true incidence of sepsis. Up to now, few data is available on the total number of blood cultures obtained and the relation to the incidence of sepsis in German ICUs.

Conditions

Timeline

Start date
2009-08-01
Primary completion
2010-12-01
Completion
2015-11-01
First posted
2011-07-07
Last updated
2016-11-23

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01388686. Inclusion in this directory is not an endorsement.

Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg (NCT01388686) · Clinical Trials Directory